Tenderwize
Zurück zur Suche

Open house discount contracts for Formoterol and Aclidiniumbromide, ATC R03AL05

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Formoterol und Aclidiniumbromid, ATC R03AL05

50/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

50 / 100

Komplexität

40 / 100

Risikofaktoren

The buyer explicitly states that this is not a public procurement under EU Directive, but a voluntary transparency publ...

No information on expected volumes or discounts. Open house model may lead to many participants, potentially low indivi...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products with active substances Formoterol and Aclidiniumbromide (ATC R03AL05)
  • Non-exclusive discount contracts under German social code (SGB V §§ 130a Abs. 8/130c Abs. 1)
Vollständige Zusammenfassung anzeigen

This is an open house (non-exclusive) discount contract agreement for pharmaceutical products containing the active substances Formoterol and Aclidiniumbromide (ATC R03AL05), organized by AOK Rheinland-Pfalz/Saarland. It is explicitly not a public procurement under EU Directive 2014/24/EU, but published for transparency. The contract runs from 01.05.2025 to 30.04.2027, with a maximum duration of 24 months per contract. Contracts can be concluded at any time from May 2025 up to April 2027, subject to monthly cut-off dates. The agreement is open to all interested pharmaceutical companies that can supply authorized medicinal products in Germany. There is no estimated value disclosed. Submission must be in paper form (not electronic). The buyer reserves the right to replace open house contracts with exclusive contracts during the term.

Risiken

The buyer explicitly states that this is not a public procurement under EU Directive, but a voluntary transparency publ...

No information on expected volumes or discounts. Open house model may lead to many participants, potentially low indivi...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Proof of authorization via Lauer-Taxe listing or AMIce database extracts

Eligibility

  • Only authorized and marketable medicines in Germany are eligible

Administrative

  • Submission of signed contract documents by specified deadlines (first deadline 31.03.2025 for start 01.05.2025; subsequent deadlines: last day of month preceding two months...

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open house discount contracts for Formoterol and Aclidiniumbromide, ATC R03AL05

Non-exclusive discount contracts for the supply of pharmaceutical products containing Formoterol and Aclidiniumbromide (ATC R03AL05). The contracts are offered to all interested pharmaceutical companies under uniform conditions. The maximum contract duration is 24 months, with the earliest start date of 01.05.2025 and all contracts ending by 30.04.2027. Contracts may be terminated by the buyer early if exclusive contracts are awarded via competitive procedure.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Vergabedetails

Veröffentlichungsdatum
12 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
162890-2025

Dokumente (1)

Ähnliche Ausschreibungen